Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for Procyclidine (compound)


PubChem
Name: Procyclidine
PubChem Compound ID: 207837
Description: A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism.
Molecular formula: C19H30ClNO
Molecular weight: 323.9 g/mol
Synonyms:
1-Pyrrolidinepropanol, alpha-cyclohexyl-alpha-phenyl-, hydrochloride, (-)-; (-)-alpha-Cyclohexyl-alpha-phenyl-1-pyrrolidinepropanol hydrochloride; 30953-82-3; (-)-Procyclidine hydrochloride
DrugBank
Identification
Name: Procyclidine
Name (isomeric): DB00387
Drug Type: small molecule
Description: A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism.
Synonyms:
Prociclidina [INN-Spanish]; Procyclidinum [INN-Latin]
Brand: Kemadrine, Elorine, Metanin, Procyclid, Prosyklidin, Kemadrin, Spamol, Triciloid, Procyklidin, Vagosin, Tricoloid, Arpicolin, Tricyclamol, Triciclidina, Osnervan, Lergine
Category: Muscarinic Antagonists, Antidyskinetics, Antiparkinson Agents
CAS number: 77-37-2
Pharmacology
Indication: For the treatment of all forms of Parkinson's Disease, as well as control of extrapyramidal reactions induced by antipsychotic agents.
Pharmacology: Procyclidine has an atropine-like action on parasympathetic-innervated peripheral structures including smooth muscle. It's antispasmodic effects are thought to be related to the blockage of central cholinergic receptors M1, M2 and M4. It is used to treat symptomatic Parkinsonism and extrapyramidal dysfunction caused by antipsychotic agents.
Mechanism of Action:
The mechanism of action is unknown. It is thought that Procyclidine acts by blocking central cholinergic receptors, and thus balancing cholinergic and dopaminergic activity in the basal ganglia. Many of its effects are due to its pharmacologic similarities with atropine. Procyclidine exerts an antispasmodic effect on smooth muscle, and may produce ...
show more »
Protein binding: Approximately 100% bound to albumin.
Toxicity: LD50=60 mg/kg (IV in mice)
Affected organisms: Humans and other mammals
Interactions
Drug interaction:
TrimethobenzamideTrimethobenzamide and Procyclidine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Monitor for enhanced anticholinergic effects.
DonepezilPossible antagonism of action
TriprolidineTriprolidine and Procyclidine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Monitor for enhanced anticholinergic effects.
TacrineThe therapeutic effects of the central acetylcholinesterase inhibitor, Tacrine, and/or the anticholinergic, Procyclidine, may be reduced due to antagonism. The interaction may be beneficial when the anticholinergic action is a side effect. Monitor for decreased efficacy of both agents.
TrospiumTrospium and Procyclidine, two anticholinergics, may cause additive anticholinergic effects and enhanced adverse/toxic effects. Monitor for enhanced anticholinergic effects.
show more »

Targets